This article is more than 5 years old. Information may no longer be current.

Halifax Biomedical receives FDA clearance for imaging software

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The FDA issued clearance to Halifax Biomedical Inc. for its image processing software, the company announced here at the American Academy of Orthopaedic Surgeons Annual Meeting.

The company’s Model-Based RSA (MBRSA) Software is an analytical software package for evaluation of orthopedic implant fixation and bone segment motion. It measures the in vivo 3-D position and relative motion of metal implants, marker beads and bone segments from calibrated stereo radiographic images.

The MBRSA Software was developed and maintained by Halifax Biomedical Inc. partner RSAcore in the Department of Orthopaedics at Leiden University Medical Center, in Leiden, Netherlands.